| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.51 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |